dalteparin has been researched along with Fetal Membranes, Premature Rupture in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Fetal Membranes, Premature Rupture: Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Subchorionic hematoma is a potentially serious complication that can occur in pregnant patients receiving enoxaparin for the prevention of thromboembolism." | 1.33 | Massive subchorionic hematoma associated with enoxaparin. ( Goodwin, TM; Lee, RH, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MartÃ-Gamboa, S | 1 |
| Savirón Cornudella, R | 1 |
| Campillos-Maza, JM | 1 |
| Lee, RH | 1 |
| Goodwin, TM | 1 |
| Stone, S | 1 |
| Hunt, BJ | 1 |
| Seed, PT | 1 |
| Parmar, K | 1 |
| Khamashta, MA | 1 |
| Poston, L | 1 |
1 review available for dalteparin and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
[Massive gestational vulvar edema. A case report and review of literature].
Topics: Albumins; Anti-Infective Agents; Anticoagulants; Cesarean Section; Edema; Enoxaparin; Exudates and T | 2014 |
2 other studies available for dalteparin and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
Massive subchorionic hematoma associated with enoxaparin.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Cesarean Section; Chorion; Enoxaparin; Factor Xa Inhibit | 2006 |
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F | 2003 |